Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation (original) (raw)

Nature volume 441, pages 366–370 (2006)Cite this article

Abstract

The eight catalytic subunits of the mammalian phosphoinositide-3-OH kinase (PI(3)K) family form the backbone of an evolutionarily conserved signalling pathway; however, the roles of most PI(3)K isoforms in organismal physiology and disease are unknown. To delineate the role of p110α, a ubiquitously expressed PI(3)K involved in tyrosine kinase and Ras signalling, here we generated mice carrying a knockin mutation (D933A) that abrogates p110α kinase activity. Homozygosity for this kinase-dead p110α led to embryonic lethality. Mice heterozygous for this mutation were viable and fertile, but displayed severely blunted signalling via insulin-receptor substrate (IRS) proteins, key mediators of insulin, insulin-like growth factor-1 and leptin action. Defective responsiveness to these hormones led to reduced somatic growth, hyperinsulinaemia, glucose intolerance, hyperphagia and increased adiposity in mice heterozygous for the D933A mutation. This signalling function of p110α derives from its highly selective recruitment and activation to IRS signalling complexes compared to p110β, the other broadly expressed PI(3)K isoform, which did not contribute to IRS-associated PI(3)K activity. p110α was the principal IRS-associated PI(3)K in cancer cell lines. These findings demonstrate a critical role for p110α in growth factor and metabolic signalling and also suggest an explanation for selective mutation or overexpression of p110α in a variety of cancers1,2.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Shayesteh, L. et al. PIK3CA is implicated as an oncogene in ovarian cancer. Nature Genet. 21, 99–102 (1999)
    Article CAS PubMed Google Scholar
  2. Samuels, Y. et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 304, 554 (2004)
    Article CAS PubMed Google Scholar
  3. Vanhaesebroeck, B., Ali, K., Bilancio, A., Geering, B. & Foukas, L. C. Signalling by PI3K isoforms: Insights from gene-targeted mice. Trends Biochem. Sci. 30, 194–204 (2005)
    Article CAS PubMed Google Scholar
  4. Bi, L., Okabe, I., Bernard, D. J., Wynshaw-Boris, A. & Nussbaum, R. L. Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110α subunit of phosphoinositide 3-kinase. J. Biol. Chem. 274, 10963–10968 (1999)
    Article CAS PubMed Google Scholar
  5. Bi, L., Okabe, I., Bernard, D. J. & Nussbaum, R. L. Early embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase. Mamm. Genome 13, 169–172 (2002)
    CAS PubMed Google Scholar
  6. Brachmann, S. M., Ueki, K., Engelman, J. A., Kahn, R. C. & Cantley, L. C. Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice. Mol. Cell. Biol. 25, 1596–1607 (2005)
    Article CAS PubMed PubMed Central Google Scholar
  7. Fruman, D. A. et al. Hypoglycemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85α. Nature Genet. 26, 379–382 (2000)
    Article CAS PubMed Google Scholar
  8. Dupont, J. & Holzenberger, M. Biology of insulin-like growth factors in development. Birth Defects Res. C Embryo Today 69, 257–271 (2003)
    Article CAS PubMed Google Scholar
  9. Lawlor, M. A. et al. Essential role of PDK1 in regulating cell size and development in mice. EMBO J. 21, 3728–3738 (2002)
    Article CAS PubMed PubMed Central Google Scholar
  10. Kozma, S. C. & Thomas, G. Regulation of cell size in growth development and human disease: PI3K, PKB and S6K. Bioessays 24, 65–71 (2002)
    Article CAS PubMed Google Scholar
  11. Choudhury, A. I. et al. The role of insulin receptor substrate 2 in hypothalamic and β cell function. J. Clin. Invest. 115, 940–950 (2005)
    Article CAS PubMed PubMed Central Google Scholar
  12. Bouret, S. G., Draper, S. J. & Simerly, R. B. Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 304, 108–110 (2004)
    Article ADS CAS PubMed Google Scholar
  13. White, M. F. Insulin signaling in health and disease. Science 302, 1710–1711 (2003)
    Article ADS CAS PubMed Google Scholar
  14. Niswender, K. D. et al. Intracellular signalling: Key enzyme in leptin-induced anorexia. Nature 413, 794–795 (2001)
    Article ADS CAS PubMed Google Scholar
  15. Niswender, K. D. et al. Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: A key mediator of insulin-induced anorexia. Diabetes 52, 227–231 (2003)
    Article CAS PubMed Google Scholar
  16. Xu, A. W. et al. PI3K integrates the action of insulin and leptin on hypothalamic neurons. J. Clin. Invest. 115, 951–958 (2005)
    Article CAS PubMed PubMed Central Google Scholar
  17. Withers, D. J. Insulin receptor substrate proteins and neuroendocrine function. Biochem. Soc. Trans. 29, 525–529 (2001)
    Article CAS PubMed Google Scholar
  18. Cho, H. et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 292, 1728–1731 (2001)
    Article ADS CAS PubMed Google Scholar
  19. Wang, Q., Bilan, P. J., Tsakiridis, T., Hinek, A. & Klip, A. Actin filaments participate in the relocalization of phosphatidylinositol 3-kinase to glucose transporter-containing compartments and in the stimulation of glucose uptake in 3T3–L1 adipocytes. Biochem. J. 331, 917–928 (1998)
    Article CAS PubMed PubMed Central Google Scholar
  20. Asano, T. et al. p110β is up-regulated during differentiation of 3T3–L1 cells and contributes to the highly insulin-responsive glucose transport activity. J. Biol. Chem. 275, 17671–17676 (2000)
    Article CAS PubMed Google Scholar
  21. Roche, S., Downward, J., Raynal, P. & Courtneidge, S. A. A function for phosphatidylinositol 3-kinase β (p85α-p110β) in fibroblasts during mitogenesis: Requirement for insulin- and lysophosphatidic acid-mediated signal transduction. Mol. Cell. Biol. 18, 7119–7129 (1998)
    Article CAS PubMed PubMed Central Google Scholar
  22. Hooshmand-Rad, R. et al. The PI 3-kinase isoforms p110α and p110β have differential roles in PDGF- and insulin-mediated signaling. J. Cell Sci. 113, 207–214 (2000)
    CAS PubMed Google Scholar
  23. Jackson, S. P. et al. PI 3-kinase p110β: A new target for antithrombotic therapy. Nature Med. 11, 507–514 (2005)
    Article CAS PubMed Google Scholar
  24. Beeton, C. A., Chance, E. M., Foukas, L. C. & Shepherd, P. R. Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110α and p110β catalytic subunits of class-Ia phosphoinositide 3-kinases. Biochem. J. 350, 353–359 (2000)
    Article CAS PubMed PubMed Central Google Scholar
  25. Kurosu, H. et al. Heterodimeric phosphoinositide 3-kinase consisting of p85 and p110β is synergistically activated by the βγ subunits of G proteins and phosphotyrosyl peptide. J. Biol. Chem. 272, 24252–24256 (1997)
    Article CAS PubMed Google Scholar
  26. Kubo, H., Hazeki, K., Takasuga, S. & Hazeki, O. Specific role of p85/p110β in GTP-binding protein-mediated activation of Akt. Biochem. J. 392, 607–614 (2005)
    Article CAS PubMed PubMed Central Google Scholar
  27. Pollak, M. N., Schernhammer, E. S. & Hankinson, S. E. Insulin-like growth factors and neoplasia. Nature Rev. Cancer 4, 505–518 (2004)
    Article CAS Google Scholar
  28. Drees, B. E., Mills, G. B., Rommel, C. & Prestwich, G. D. Therapeutic potential of phosphoinositide 3-kinase inhibitors. Expert Opin. Ther. Patents 14, 703–732 (2004)
    Article CAS Google Scholar
  29. Amaravadi, R. & Thompson, C. B. The survival kinases Akt and Pim as potential pharmacological targets. J. Clin. Invest. 115, 2618–2624 (2005)
    Article CAS PubMed PubMed Central Google Scholar
  30. Klippel, A., Escobedo, J. A., Hirano, M. & Williams, L. T. The interaction of small domains between the subunits of phosphatidylinositol 3-kinase determines enzyme activity. Mol. Cell. Biol. 14, 2675–2685 (1994)
    Article CAS PubMed PubMed Central Google Scholar

Download references

Acknowledgements

We thank M. Camps, T. Ruckle, C. Rommel (Serono Pharmaceutical Research Institute) and PIramed for pharmacological agents; W. Fantl for antibody reagents; and T. Arnett and I. Orriss for providing access and help with the DEXA scanner. Personal support for L.F., M.C. and K.O. was provided in part by a European Union FP5 Programme grant, and for W.P. by a European Union grant. The main grant support for this project was by Diabetes UK and the Ludwig Institute for Cancer Research (to B.V.) and by the Wellcome Trust and MRC (to D.J.W.), with additional support of the Biotechnology and Biological Science Research Council (to B.V.). The ISCR Gene Targeting Laboratory was supported by the Biotechnology and Biological Science Research Council.

Author information

Author notes

  1. Klaus Okkenhaug
    Present address: Babraham Institute, Cambridge, CB2 4AT, UK

Authors and Affiliations

  1. Ludwig Institute for Cancer Research, 91 Riding House Street, W1W 7BS, London, UK
    Lazaros C. Foukas, Wayne Pearce, Klaus Okkenhaug, Emma Peskett & Bart Vanhaesebroeck
  2. Centre for Diabetes and Endocrinology, University College London, Rayne Institute, 5 University Street, WC1E 6JJ, London, UK
    Marc Claret & Dominic J. Withers
  3. Gene Targeting Laboratory, The Institute for Stem Cell Research, University of Edinburgh, West Mains Road, EH9 3JQ, Edinburgh, UK
    Stephen Meek & Andrew J. H. Smith
  4. Department of Medicine, University of Fribourg, 14 Chemin du Musée, CH-1700, Switzerland
    Sara Sancho
  5. Department of Biochemistry and Molecular Biology, University College London, Gower Street, WC1E 6BT, London, UK
    Bart Vanhaesebroeck

Authors

  1. Lazaros C. Foukas
    You can also search for this author inPubMed Google Scholar
  2. Marc Claret
    You can also search for this author inPubMed Google Scholar
  3. Wayne Pearce
    You can also search for this author inPubMed Google Scholar
  4. Klaus Okkenhaug
    You can also search for this author inPubMed Google Scholar
  5. Stephen Meek
    You can also search for this author inPubMed Google Scholar
  6. Emma Peskett
    You can also search for this author inPubMed Google Scholar
  7. Sara Sancho
    You can also search for this author inPubMed Google Scholar
  8. Andrew J. H. Smith
    You can also search for this author inPubMed Google Scholar
  9. Dominic J. Withers
    You can also search for this author inPubMed Google Scholar
  10. Bart Vanhaesebroeck
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toBart Vanhaesebroeck.

Ethics declarations

Competing interests

Reprints and permissions information is available at npg.nature.com/reprintsandpermissions. The authors declare no competing financial interests.

Supplementary information

Supplementary Notes

This file contains Supplementary Figures and Legends 1–4, Supplementary Methods and Supplementary Table 1. These provide a detailed description of the gene targeting strategy, organ and cell size measurements, additional data from glucose and insulin tolerance tests and a list of the organs subjected to histological examination. (PDF 200 kb)

Rights and permissions

About this article

Cite this article

Foukas, L., Claret, M., Pearce, W. et al. Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation.Nature 441, 366–370 (2006). https://doi.org/10.1038/nature04694

Download citation

This article is cited by